EU đặt mua 220.000 liệu trình điều trị COVID-19 của GlaxoSmithKline

(TTXVN/Vietnam+) 08:47 29/07/2021

Ngày 28/7, Liên minh châu Âu (EU) cho biết đã ký một thỏa thuận với công ty dược phẩm GlaxoSmithKline của Anh về việc cung cấp lên đến 220.000 liệu trình thuốc Sotrovimab điều trị bệnh nhân COVID-19 bằng kháng thể đơn dòng mà hãng này đang phát triển. GlaxoSmithKline cùng ngày cũng đã xác nhận thỏa thuận này.

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